EU đặt mua 220.000 liệu trình điều trị COVID-19 của GlaxoSmithKline

(TTXVN/Vietnam+) 08:47 29/07/2021

Ngày 28/7, Liên minh châu Âu (EU) cho biết đã ký một thỏa thuận với công ty dược phẩm GlaxoSmithKline của Anh về việc cung cấp lên đến 220.000 liệu trình thuốc Sotrovimab điều trị bệnh nhân COVID-19 bằng kháng thể đơn dòng mà hãng này đang phát triển. GlaxoSmithKline cùng ngày cũng đã xác nhận thỏa thuận này.

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